Hippocratic AI

Hippocratic AI is a healthcare-AI company founded in 2023 to build safety-focused, patient-facing generative-AI agents for the large set of clinical tasks that are non-diagnostic — post-discharge follow-up calls, chronic-care check-ins, medication reminders, appointment preparation, and care-management outreach. Its central design premise is safety: rather than a single general model, it uses a constellation of specialized models with clinical guardrails and emphasizes extensive clinician testing before any agent is deployed. The company reached an approximately $3.5 billion valuation in its November 2025 Series C, with investors including Andreessen Horowitz, General Catalyst, and Kleiner Perkins.

Hippocratic AI's agents run over voice and text and are positioned to extend the reach of nursing and care-management staff rather than replace clinical judgment — the AI handles routine outreach at scale and escalates to a human when needed. By 2026 the company reported deployments across 50-plus US health systems and payers, more than 100 million patient interactions, and an expansion into nurse-workflow tools and an omnichannel "AI Front Door" for patient access. As with all patient-facing clinical AI, the open questions are safety at scale, liability, and regulatory treatment; the company leans into these with a safety-first framing and heavy clinician review.